Carolyn Horton

1.8k total citations
40 papers, 296 citations indexed

About

Carolyn Horton is a scholar working on Genetics, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Carolyn Horton has authored 40 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 12 papers in Pathology and Forensic Medicine and 11 papers in Surgery. Recurrent topics in Carolyn Horton's work include BRCA gene mutations in cancer (16 papers), Genomics and Rare Diseases (11 papers) and Genetic factors in colorectal cancer (11 papers). Carolyn Horton is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Genomics and Rare Diseases (11 papers) and Genetic factors in colorectal cancer (11 papers). Carolyn Horton collaborates with scholars based in United States, Türkiye and Australia. Carolyn Horton's co-authors include Marcy E. Richardson, Holly LaDuca, Amal Yussuf, Gary J. Alter, Judy E. Garber, Rachid Karam, Brittany Bychkovsky, Huma Q. Rana, Andreana N. Holowatyj and Colin C. Young and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carolyn Horton

33 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolyn Horton United States 9 121 87 74 71 63 40 296
Mona S. Jahromi United States 10 27 0.2× 84 1.0× 20 0.3× 49 0.7× 42 0.7× 13 259
Mark Katory United Kingdom 9 42 0.3× 78 0.9× 147 2.0× 101 1.4× 43 0.7× 16 294
Carmen M. Perrino United States 10 29 0.2× 72 0.8× 132 1.8× 33 0.5× 37 0.6× 28 256
Hiroko Gotoda Japan 10 56 0.5× 80 0.9× 75 1.0× 26 0.4× 19 0.3× 22 352
Miriam Deniz Germany 10 23 0.2× 87 1.0× 57 0.8× 23 0.3× 45 0.7× 24 207
Mohammed Haseebuddin United States 10 31 0.3× 80 0.9× 66 0.9× 14 0.2× 36 0.6× 22 318
D. Schweinitz Germany 10 23 0.2× 71 0.8× 101 1.4× 28 0.4× 23 0.4× 15 268
Mona K. Wu Canada 10 46 0.4× 133 1.5× 248 3.4× 29 0.4× 26 0.4× 11 409
Trudie E. Muir United States 6 21 0.2× 118 1.4× 68 0.9× 45 0.6× 21 0.3× 7 307
Asad Haider United States 6 26 0.2× 75 0.9× 33 0.4× 49 0.7× 33 0.5× 13 287

Countries citing papers authored by Carolyn Horton

Since Specialization
Citations

This map shows the geographic impact of Carolyn Horton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn Horton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn Horton more than expected).

Fields of papers citing papers by Carolyn Horton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn Horton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn Horton. The network helps show where Carolyn Horton may publish in the future.

Co-authorship network of co-authors of Carolyn Horton

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn Horton. A scholar is included among the top collaborators of Carolyn Horton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn Horton. Carolyn Horton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, A., Linda M. Polfus, Brittany Bychkovsky, et al.. (2025). Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism. Clinical Cancer Research. 31(13). 2814–2823.
2.
Bychkovsky, Brittany, Nihat Buğra Ağaoğlu, Carolyn Horton, et al.. (2025). Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes. JAMA Network Open. 8(1). e2451361–e2451361. 1 indexed citations
3.
4.
Towne, Meghan C., et al.. (2024). P644: Unlocking the code: When SpliceAI falls short in variant assessment. SHILAP Revista de lepidopterología. 2. 101550–101550.
5.
Rañola, John Michael O., Carolyn Horton, Tina Pesaran, et al.. (2024). Assigning credit where it is due: an information content score to capture the clinical value of multiplexed assays of variant effect. BMC Bioinformatics. 25(1). 295–295. 1 indexed citations
6.
Young, Colin C., Carolyn Horton, Bhuvan Molparia, et al.. (2024). Solving Missing Heritability in Patients With Familial Adenomatous Polyposis With DNA-RNA Paired Testing. JCO Precision Oncology. 8(8). e2300404–e2300404. 3 indexed citations
7.
Tavtigian, Sean V., et al.. (2024). Variant of Uncertain Significance Patterns among Patients with Early-Onset Colorectal Cancer. Cancer Research Communications. 5(2). 309–317. 2 indexed citations
8.
Ağaoğlu, Nihat Buğra, Brittany Bychkovsky, Carolyn Horton, et al.. (2024). Cancer burden in individuals with single versus double pathogenic variants in cancer susceptibility genes. SHILAP Revista de lepidopterología. 2. 101829–101829. 5 indexed citations
9.
Holowatyj, Andreana N., M. Kay Washington, & Carolyn Horton. (2023). Is Appendiceal Cancer a Lynch Syndrome–Associated Cancer?—Reply. JAMA Oncology. 9(6). 869–869. 2 indexed citations
10.
Bychkovsky, Brittany, Min‐Tzu Lo, Amal Yussuf, et al.. (2023). Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast Cancer Research and Treatment. 200(1). 63–72.
11.
Yussuf, Amal, et al.. (2023). Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort. Genetics in Medicine. 25(11). 100937–100937. 6 indexed citations
12.
13.
Tavtigian, Sean V., et al.. (2023). Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer. Journal of Clinical Oncology. 41(26). 4279–4289. 15 indexed citations
14.
Horton, Carolyn, Lily Hoang, Min‐Tzu Lo, et al.. (2022). OP036: Application of RNA sequencing evidence improves equity in variant interpretation. Genetics in Medicine. 24(3). S363–S363.
15.
Horton, Carolyn, Holly LaDuca, Michelle Jackson, et al.. (2022). Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield. The Journal of Clinical Endocrinology & Metabolism. 107(5). e1917–e1923. 19 indexed citations
16.
Bychkovsky, Brittany, Nihat Buğra Ağaoğlu, Carolyn Horton, et al.. (2022). Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2. JAMA Oncology. 8(11). 1598–1598. 48 indexed citations
17.
Fayer, Shawn, Carolyn Horton, Jennifer N. Dines, et al.. (2021). Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. The American Journal of Human Genetics. 108(12). 2248–2258. 53 indexed citations
18.
Kulkarni, Sanjeev R., R Powles, Seema Singhal, et al.. (1998). Second cancers and non-autologous bone marrow transplantation for haematological malignancies: Single centre experience of 883 patients.. Queensland's institutional digital repository (The University of Queensland). 21(10). 2 indexed citations
19.
Alter, Gary J., Carolyn Horton, & Carolyn Horton. (1994). Buried penis as a contraindication for circumcision.. PubMed. 178(5). 487–90. 28 indexed citations
20.
Green, Manfred S., Carolyn Horton, Monica B. Spaulding, et al.. (1983). Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 1(9). 559–565. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mona S. Jahromi Breakdown of academic impact, for papers by Mark Katory Breakdown of academic impact, for papers by Carmen M. Perrino Breakdown of academic impact, for papers by Hiroko Gotoda Breakdown of academic impact, for papers by Miriam Deniz Breakdown of academic impact, for papers by Mohammed Haseebuddin Breakdown of academic impact, for papers by D. Schweinitz Breakdown of academic impact, for papers by Mona K. Wu Breakdown of academic impact, for papers by Trudie E. Muir Breakdown of academic impact, for papers by Asad Haider
Rankless by CCL
2026